TSHA logo

Taysha Gene Therapies, Inc. (TSHA) Total Expenses

Annual Total Expenses:

$97.63M-$29.39M(-23.14%)
December 31, 2024

Summary

  • As of today, TSHA annual total expenses is $97.63 million, with the most recent change of -$29.39 million (-23.14%) on December 31, 2024.
  • During the last 3 years, TSHA annual total expenses has fallen by -$76.89 million (-44.06%).
  • TSHA annual total expenses is now -44.06% below its all-time high of $174.52 million, reached on December 31, 2021.

Performance

TSHA Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

Quarterly Total Expenses:

$32.73M+$3.87M(+13.39%)
September 30, 2025

Summary

  • As of today, TSHA quarterly total expenses is $32.73 million, with the most recent change of +$3.87 million (+13.39%) on September 30, 2025.
  • Over the past year, TSHA quarterly total expenses has increased by +$5.42 million (+19.85%).
  • TSHA quarterly total expenses is now -73.13% below its all-time high of $121.83 million, reached on September 30, 2023.

Performance

TSHA Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

TSHA Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-23.1%+19.9%
3Y3 Years-44.1%+23.4%
5Y5 Years+8656.1%+117.6%

TSHA Total Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-44.1%at low-73.1%+174.2%
5Y5-Year-44.1%+8656.1%-73.1%+174.2%
All-TimeAll-Time-44.1%+8656.1%-73.1%+174.2%

TSHA Total Expenses History

DateAnnualQuarterly
Sep 2025
-
$32.73M(+13.4%)
Jun 2025
-
$28.87M(+21.1%)
Mar 2025
-
$23.83M(+14.5%)
Dec 2024
$97.63M(-23.1%)
$20.81M(-23.8%)
Sep 2024
-
$27.31M(+23.9%)
Jun 2024
-
$22.04M(-19.8%)
Mar 2024
-
$27.47M(+162.2%)
Dec 2023
$127.02M(-24.6%)
-$44.14M(-136.2%)
Sep 2023
-
$121.83M(+351.4%)
Jun 2023
-
$26.99M(+20.9%)
Mar 2023
-
$22.33M(-61.7%)
Dec 2022
$168.52M
$58.23M(+119.5%)
DateAnnualQuarterly
Sep 2022
-
$26.53M(-22.2%)
Jun 2022
-
$34.09M(-32.2%)
Mar 2022
-
$50.32M(-0.1%)
Dec 2021
$174.52M(+190.8%)
$50.39M(-1.6%)
Sep 2021
-
$51.19M(+25.1%)
Jun 2021
-
$40.93M(+27.8%)
Mar 2021
-
$32.02M(+74.8%)
Dec 2020
$60.01M(+5282.2%)
-
Dec 2020
-
$18.32M(+21.8%)
Sep 2020
-
$15.04M(+177.0%)
Mar 2020
-
$5.43M(+387.1%)
Dec 2019
$1.11M
-
Dec 2019
-
$1.11M

FAQ

  • What is Taysha Gene Therapies, Inc. annual total expenses?
  • What is the all-time high annual total expenses for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. annual total expenses year-on-year change?
  • What is Taysha Gene Therapies, Inc. quarterly total expenses?
  • What is the all-time high quarterly total expenses for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. quarterly total expenses year-on-year change?

What is Taysha Gene Therapies, Inc. annual total expenses?

The current annual total expenses of TSHA is $97.63M

What is the all-time high annual total expenses for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high annual total expenses is $174.52M

What is Taysha Gene Therapies, Inc. annual total expenses year-on-year change?

Over the past year, TSHA annual total expenses has changed by -$29.39M (-23.14%)

What is Taysha Gene Therapies, Inc. quarterly total expenses?

The current quarterly total expenses of TSHA is $32.73M

What is the all-time high quarterly total expenses for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high quarterly total expenses is $121.83M

What is Taysha Gene Therapies, Inc. quarterly total expenses year-on-year change?

Over the past year, TSHA quarterly total expenses has changed by +$5.42M (+19.85%)
On this page